Confidence Aware Neural Networks for Skin Cancer Detection

Deep learning (DL) models have received particular attention in medical imaging due to their promising pattern recognition capabilities. However, Deep Neural Networks (DNNs) require a huge amount of data, and because of the lack of sufficient data in this field, transfer learning can be a great solution. DNNs used for disease diagnosis meticulously concentrate on improving the accuracy of predictions without providing a figure about their confidence of predictions. Knowing how much a DNN model is confident in a computer-aided diagnosis model is necessary for gaining clinicians' confidence and trust in DL-based solutions. To address this issue, this work presents three different methods for quantifying uncertainties for skin cancer detection from images. It also comprehensively evaluates and compares performance of these DNNs using novel uncertainty-related metrics. The obtained results reveal that the predictive uncertainty estimation methods are capable of flagging risky and erroneous predictions with a high uncertainty estimate. We also demonstrate that ensemble approaches are more reliable in capturing uncertainties through inference.

Applications of Epileptic Seizures Detection in Neuroimaging Modalities Using Deep Learning Techniques: Methods, Challenges, and Future Works

Epileptic seizures are a type of neurological disorder that affect many people worldwide. Specialist physicians and neurologists take advantage of structural and functional neuroimaging modalities to diagnose various types of epileptic seizures. Neuroimaging modalities assist specialist physicians considerably in analyzing brain tissue and the changes made in it. One method to accelerate the accurate and fast diagnosis of epileptic seizures is to employ computer aided diagnosis systems (CADS) based on artificial intelligence (AI) and functional and structural neuroimaging modalities. AI encompasses a variety of areas, and one of its branches is deep learning (DL). Not long ago, and before the rise of DL algorithms, feature extraction was an essential part of every conventional machine learning method, yet handcrafting features limit these models' performances to the knowledge of system designers. DL methods resolved this issue entirely by automating the feature extraction and classification process; applications of these methods in many fields of medicine, such as the diagnosis of epileptic seizures, have made notable improvements. In this paper, a comprehensive overview of the types of DL methods exploited to diagnose epileptic seizures from various neuroimaging modalities has been studied. Additionally, rehabilitation systems and cloud computing in epileptic seizures diagnosis applications have been exactly investigated using various modalities.

UncertaintyFuseNet: Robust Uncertainty-aware Hierarchical Feature Fusion with Ensemble Monte Carlo Dropout for COVID-19 Detection

The COVID-19 (Coronavirus disease 2019) has infected more than 151 million people and caused approximately 3.17 million deaths around the world up to the present. The rapid spread of COVID-19 is continuing to threaten human's life and health. Therefore, the development of computer-aided detection (CAD) systems based on machine and deep learning methods which are able to accurately differentiate COVID-19 from other diseases using chest computed tomography (CT) and X-Ray datasets is essential and of immediate priority. Different from most of the previous studies which used either one of CT or X-ray images, we employed both data types with sufficient samples in implementation. On the other hand, due to the extreme sensitivity of this pervasive virus, model uncertainty should be considered, while most previous studies have overlooked it. Therefore, we propose a novel powerful fusion model named $UncertaintyFuseNet$ that consists of an uncertainty module: Ensemble Monte Carlo (EMC) dropout. The obtained results prove the effectiveness of our proposed fusion for COVID-19 detection using CT scan and X-Ray datasets. Also, our proposed $UncertaintyFuseNet$ model is significantly robust to noise and performs well with the previously unseen data. The source codes and models of this study are available at: https://github.com/moloud1987/UncertaintyFuseNet-for-COVID-19-Classification.

Applications of Deep Learning Techniques for Automated Multiple Sclerosis Detection Using Magnetic Resonance Imaging: A Review

Multiple Sclerosis (MS) is a type of brain disease which causes visual, sensory, and motor problems for people with a detrimental effect on the functioning of the nervous system. In order to diagnose MS, multiple screening methods have been proposed so far; among them, magnetic resonance imaging (MRI) has received considerable attention among physicians. MRI modalities provide physicians with fundamental information about the structure and function of the brain, which is crucial for the rapid diagnosis of MS lesions. Diagnosing MS using MRI is time-consuming, tedious, and prone to manual errors. Hence, computer aided diagnosis systems (CADS) based on artificial intelligence (AI) methods have been proposed in recent years for accurate diagnosis of MS using MRI neuroimaging modalities. In the AI field, automated MS diagnosis is being conducted using (i) conventional machine learning and (ii) deep learning (DL) techniques. The conventional machine learning approach is based on feature extraction and selection by trial and error. In DL, these steps are performed by the DL model itself. In this paper, a complete review of automated MS diagnosis methods performed using DL techniques with MRI neuroimaging modalities are discussed. Also, each work is thoroughly reviewed and discussed. Finally, the most important challenges and future directions in the automated MS diagnosis using DL techniques coupled with MRI modalities are presented in detail.

Time Series Forecasting of New Cases and New Deaths Rate for COVID-19 using Deep Learning Methods

Covid-19 has been started in the year 2019 and imposed restrictions in many countries and costs organisations and governments. Predicting the number of new cases and deaths during this period can be a useful step in predicting the costs and facilities required in the future. The purpose of this study is to predict new cases and death rate for seven days ahead. Deep learning methods and statistical analysis model these predictions for 100 days. Six different deep learning methods are examined for the data adopted from the WHO website. Three methods are known as LSTM, Convolutional LSTM, and GRU. The bi-directional mode is then considered for each method to forecast the rate of new cases and new deaths for Australia and Iran countries. This study is novel as it attempts to implement the mentioned three deep learning methods, along with their Bi-directional models, to predict COVID-19 new cases and new death rate time series. All methods are compared, and results are presented. The results are examined in the form of graphs and statistical analyses. The results show that the Bi-directional models have lower error than other models. Several error evaluation metrics are presented to compare all models, and finally, the superiority of Bi-directional methods are determined. The experimental results and statistical test show on datasets to compare the proposed method with other baseline methods. This research could be useful for organisations working against COVID-19 and determining their long-term plans.

CNN AE: Convolution Neural Network combined with Autoencoder approach to detect survival chance of COVID 19 patients

In this paper, we propose a novel method named CNN-AE to predict survival chance of COVID-19 patients using a CNN trained on clinical information. To further increase the prediction accuracy, we use the CNN in combination with an autoencoder. Our method is one of the first that aims to predict survival chance of already infected patients. We rely on clinical data to carry out the prediction. The motivation is that the required resources to prepare CT images are expensive and limited compared to the resources required to collect clinical data such as blood pressure, liver disease, etc. We evaluate our method on a publicly available clinical dataset of deceased and recovered patients which we have collected. Careful analysis of the dataset properties is also presented which consists of important features extraction and correlation computation between features. Since most of COVID-19 patients are usually recovered, the number of deceased samples of our dataset is low leading to data imbalance. To remedy this issue, a data augmentation procedure based on autoencoders is proposed. To demonstrate the generality of our augmentation method, we train random forest and Na\"ive Bayes on our dataset with and without augmentation and compare their performance. We also evaluate our method on another dataset for further generality verification. Experimental results reveal the superiority of CNN-AE method compared to the standard CNN as well as other methods such as random forest and Na\"ive Bayes. COVID-19 detection average accuracy of CNN-AE is 96.05% which is higher than CNN average accuracy of 92.49%. To show that clinical data can be used as a reliable dataset for COVID-19 survival chance prediction, CNN-AE is compared with a standard CNN which is trained on CT images.

An Overview on Artificial Intelligence Techniques for Diagnosis of Schizophrenia Based on Magnetic Resonance Imaging Modalities: Methods, Challenges, and Future Works

Schizophrenia (SZ) is a mental disorder that typically emerges in late adolescence or early adulthood. It reduces the life expectancy of patients by 15 years. Abnormal behavior, perception of emotions, social relationships, and reality perception are among its most significant symptoms. Past studies have revealed the temporal and anterior lobes of hippocampus regions of brain get affected by SZ. Also, increased volume of cerebrospinal fluid (CSF) and decreased volume of white and gray matter can be observed due to this disease. The magnetic resonance imaging (MRI) is the popular neuroimaging technique used to explore structural/functional brain abnormalities in SZ disorder owing to its high spatial resolution. Various artificial intelligence (AI) techniques have been employed with advanced image/signal processing methods to obtain accurate diagnosis of SZ. This paper presents a comprehensive overview of studies conducted on automated diagnosis of SZ using MRI modalities. Main findings, various challenges, and future works in developing the automated SZ detection are described in this paper.

Fusion of convolution neural network, support vector machine and Sobel filter for accurate detection of COVID-19 patients using X-ray images

The coronavirus (COVID-19) is currently the most common contagious disease which is prevalent all over the world. The main challenge of this disease is the primary diagnosis to prevent secondary infections and its spread from one person to another. Therefore, it is essential to use an automatic diagnosis system along with clinical procedures for the rapid diagnosis of COVID-19 to prevent its spread. Artificial intelligence techniques using computed tomography (CT) images of the lungs and chest radiography have the potential to obtain high diagnostic performance for Covid-19 diagnosis. In this study, a fusion of convolutional neural network (CNN), support vector machine (SVM), and Sobel filter is proposed to detect COVID-19 using X-ray images. A new X-ray image dataset was collected and subjected to high pass filter using a Sobel filter to obtain the edges of the images. Then these images are fed to CNN deep learning model followed by SVM classifier with ten-fold cross validation strategy. This method is designed so that it can learn with not many data. Our results show that the proposed CNN-SVM with Sobel filtering (CNN-SVM+Sobel) achieved the highest classification accuracy of 99.02% in accurate detection of COVID-19. It showed that using Sobel filter can improve the performance of CNN. Unlike most of the other researches, this method does not use a pre-trained network. We have also validated our developed model using six public databases and obtained the highest performance. Hence, our developed model is ready for clinical application